Orchestra BioMed Holdings, Inc.

Ownership Transactions Reported by 20 Insiders

Symbol
OBIO on Nasdaq
Location
150 Union Square Drive, New Hope, PA

Insiders trading volume in the past year

Orchestra BioMed Holdings, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Medtronic plc 10%+ Owner $94.1M Dec 31, 2023
Rtw Investments, Lp 10%+ Owner $90.2M Apr 13, 2023
Roderick Wong Chief Executive Officer, Director, 10%+ Owner $45M Jan 24, 2023
HSAC 2 Holdings, LLC 10%+ Owner $8.78M Aug 5, 2024
David P. Hochman Chief Executive Officer and Chairperson, Director $6.83M +$119K +1.77% Dec 18, 2024
Darren Sherman President and Chief Operating Officer, Director $4.76M -$195K -3.93% Dec 5, 2024
William Reed Little Executive Vice President, Corporate Development & Strategy $2.16M +$28K +1.32% May 30, 2024
Andrew Taylor Chief Financial Officer $1.97M +$4.83K +0.25% Dec 19, 2024
Eric S. Fain Director $548K -$30.7K -5.3% Sep 6, 2024
Jason Aryeh Director $479K Jun 20, 2024
Michael Kaswan Chief Financial Officer $176K Apr 12, 2023
Pamela Connealy Director $149K Jun 20, 2024
David Pacitti Director $123K Jun 20, 2024
Yuval Mika General Manager and Chief Technology Officer, Bioelectronic Therapies $96.7K May 8, 2024
John Prosper Mack Director $66.3K Aug 7, 2024
Eric A. Md Rose Director $52.8K Jun 20, 2024
Geoffrey Wade Smith Director $22.6K Jul 20, 2023
George Papandreou General Manager and Senior Vice President, Focal Therapies $21.6K May 8, 2024
Joshua Aiello Principal Accounting Officer $5.4K May 8, 2024
Perceptive Advisors Llc 10%+ Owner Jul 11, 2024

Recent Insider Transactions by Companies or Individuals for Orchestra BioMed Holdings, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.